Needle Free Diabetes Management Market Shares, Strategies And Forecasts Worldwid

Posted by akshayparmar on November 17th, 2017

"Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the needle free diabetes management market was valued at USD 3,767.50 Mn in 2016, and is expected to reach USD 8,644.60 Mn by 2025, expanding at a CAGR of 16.8% from 2017 to 2025.

View Full Report with TOC @ http://www.acutemarketreports.com/report/needle-free-diabetes-management-market

Market Insights:

Diabetes is majorly classified into Type 1 diabetes (due to b-cell destruction, usually leading to absolute insulin deficiency), Type 2 diabetes (due to a progressive loss of insulin secretion on the background of insulin resistance) and gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes). According to the International Diabetes Federation, in 2015 about 415 million people were observed suffering with diabetes and by 2040 the number is expected to soar to 642 million worldwide. In 2015, North America and Caribbean comprised patient population of 44.3 million,

Market Competition Assessment:

The needle free diabetes management market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Zogenix, Inc., 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Inc., Medtronic, Inc., Johnson & Johnson, Inc., Pancreum LLC, Tandem Diabetes Care, Inc., JDRF, and Akra Dermojet.

Key Market Movements:

• Rising prevalence of diabetes worldwide as is claimed as one of the most chronic diseases if not well managed and is expected to reach alarming levels in the coming years
• The technology to manage diabetes is developing at significant pace some ground breaking innovations in the field of artificial pancreas are considered to change the needle free diabetes management market"

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope

Chapter 2 Executive Summary
2.1 Global Needle Free Diabetes Management Market, by Devices Type, 2015 v/s 2022 (Value %)
2.2 Global Needle Free Diabetes Management Market, by Geography, 2015 (Value %)

Chapter 6 Company Profiles
6.1 Zogenix, Inc.
6.1.1 Zogenix, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
6.2 3M 
6.2.1 3M: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
6.3 Antares Pharma Inc.
6.3.1 Antares Pharma Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
6.4 Glide Pharmaceutical Technologies Ltd.

About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us :

Name : Chris Paul

ACUTE MARKET REPORTS

Designation : Global Sales Manager

Toll Free(US/CANADA): +1-855-455-8662

Email : sales@acutemarketreports.com

Website :http://www.acutemarketreports.com